These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 30999879)

  • 21. [Pulmonal bacillus Calmette-Guérin infection two years after intravesical bacillus Calmette-Guérin installation].
    Harbjerg JL; Bjerre CC; Lillebæk T; Weinreich UM
    Ugeskr Laeger; 2014 Dec; 176(25A):. PubMed ID: 25497624
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ruptured mycotic abdominal aortic aneurysm secondary to Mycobacterium bovis after intravesical treatment with bacillus Calmette-Guérin.
    Harding GE; Lawlor DK
    J Vasc Surg; 2007 Jul; 46(1):131-4. PubMed ID: 17606130
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bacillus Calmette-Guérin (BCG) infection following intravesical BCG administration as adjunctive therapy for bladder cancer: incidence, risk factors, and outcome in a single-institution series and review of the literature.
    Pérez-Jacoiste Asín MA; Fernández-Ruiz M; López-Medrano F; Lumbreras C; Tejido Á; San Juan R; Arrebola-Pajares A; Lizasoain M; Prieto S; Aguado JM
    Medicine (Baltimore); 2014 Oct; 93(17):236-254. PubMed ID: 25398060
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Disseminated Bacillus Calmette-Guérin (BCG) infection with pulmonary and renal involvement: A rare complication of BCG immunotherapy. A case report and narrative review.
    Marques M; Vazquez D; Sousa S; Mesquita G; Duarte M; Ferreira R
    Pulmonology; 2020; 26(6):346-352. PubMed ID: 31711964
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Management of complications of bacillus Calmette-Guérin immunotherapy in the treatment of bladder cancer.
    Huang TC
    Ann Pharmacother; 2000 Apr; 34(4):529-32. PubMed ID: 10772442
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A case of disseminated Mycobacterium bovis 2 years post-intravesicular Bacillus Calmette-Guérin therapy for superficial urinary bladder cancer.
    Robinson ARL; Radhakrishnan R; Horvath R; Pandey S
    Intern Med J; 2017 Jul; 47(7):820-823. PubMed ID: 28677313
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Complications following intravesical bacillus Calmette-Guerin treatment for bladder cancer: a case series of 22 patients.
    Pommier JD; Ben Lasfar N; Van Grunderbeeck N; Burdet C; Laouénan C; Rioux C; Pierre-Audigier C; Meybeck A; Choudat L; Benchikh A; Nguyen S; Bouvet E; Yeni P; Yazdanpanah Y; Joly V
    Infect Dis (Lond); 2015; 47(10):725-31. PubMed ID: 26077036
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mycobacterium Bovis Causing Mycotic Aneurysm Secondary to Intravesical Treatment with Bacillus Calmette-Guérin: A Case Report.
    Zaza SI; Ghasemzadeh A; Bennett KM
    Ann Vasc Surg; 2022 Feb; 79():437.e1-437.e6. PubMed ID: 34644643
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tuberculosis complications after BCG treatment for urinary bladder cancer.
    Naudžiūnas A; Juškaitė R; Žiaugrytė I; Unikauskas A; Varanauskienė E; Mašanauskienė E
    Medicina (Kaunas); 2012; 48(11):563-5. PubMed ID: 23455890
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mycobacterium bovis Cerebellar Abscess Following Treatment With Bacillus Calmette-Guérin.
    Sheron MW; Holt SL; Ingram CW
    J Pharm Pract; 2017 Jun; 30(3):378-380. PubMed ID: 26966140
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mycobacterium bovis infection of an aortobifemoral bypass graft with Streptococcus intermedius superinfection after intravesical bacillus Calmette-Guérin immunotherapy for bladder cancer.
    Dubert M; Abihssira S; Diamantis S; Guenin R; Messaoudi R; Roux AL; Rouis K; Lillo A; Surgers L; Douard R; Julia P; Lebeaux D
    Infection; 2021 Apr; 49(2):345-348. PubMed ID: 32749595
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Muscular pseudotumor revealing a mycobacterial granuloma after bacillus Calmette-Guérin therapy.
    Tailbaut E; Monge M; Compain F; Pacheco A; Charles P; Richaud C
    Rev Med Interne; 2022 Dec; 43(12):743-745. PubMed ID: 36184335
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mediastinal mass mimicking a tumor in a patient with bladder cancer after Bacillus Calmette-Guerin treatment.
    Somoskovi A; Carlyn C; Dormandy J; Salfinger M
    Eur J Clin Microbiol Infect Dis; 2007 Dec; 26(12):937-40. PubMed ID: 17899227
    [TBL] [Abstract][Full Text] [Related]  

  • 34.
    Williams A; Arnold B; Gwynne-Jones DP
    Arthroplast Today; 2019 Dec; 5(4):416-420. PubMed ID: 31886382
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mycobacterium bovis vertebral osteomyelitis as a complication of intravesical BCG use.
    Abu-Nader R; Terrell CL
    Mayo Clin Proc; 2002 Apr; 77(4):393-7. PubMed ID: 11936937
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mycobacterium bovis discitis as a complication of intravesical Bacillus Calmette-Guérin therapy.
    Colebatch AN; Mounce KE
    J Clin Rheumatol; 2010 Mar; 16(2):74-5. PubMed ID: 20130477
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ruptured aortic aneurysm due to Mycobacterium bovis BCG with a delayed bacteriological diagnosis due to false negative result of the MPB 64 immunochromatographic assay.
    Simar J; Belkhir L; Tombal B; André E
    BMC Res Notes; 2017 Jan; 10(1):64. PubMed ID: 28126017
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [BCG infection following intravesicular immunotherapy for bladder cancer].
    Levi L; Groh M; De Castro N; Bergeron A; Schlemmer F
    Rev Mal Respir; 2018 Apr; 35(4):416-429. PubMed ID: 29754838
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Histopathology of Disseminated Mycobacterium bovis Infection Complicating Intravesical BCG Immunotherapy for Urothelial Carcinoma.
    Larsen BT; Smith ML; Grys TE; Vikram HR; Colby TV
    Int J Surg Pathol; 2015 May; 23(3):189-95. PubMed ID: 25614462
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mycobacterial sepsis following intravesical instillation of bacillus Calmette-Guérin.
    Garyfallou GT
    Acad Emerg Med; 1996 Feb; 3(2):157-60. PubMed ID: 8808378
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.